Survey Highlights Successes and Challenges for Early Adopters of Clinical NGS | GenomeWeb

This article was originally published July 29.

NEW YORK (GenomeWeb) — As interest in using clinical sequencing to personalize medicine begins to expand past the initial vanguard of early adopters, researchers from several institutions participating in a College of American Pathologists workgroup have attempted to tease out some of the decision-making behind the implementation of these pioneering programs in hopes of helping to guide the future spread of genomic medicine.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.